Skip to main content
Home
Search
Search for Disease
NEW
Search for Combinatorial Drug (CBD)
NEW
Search for Repurposed Drug (RPD)
NEW
Search for Drug Off-target (DOT)
NEW
Search for Drug
Search for Drug Therapeutic Target (DTT)
Search for Drug Transporter (DTP)
Search for Drug-Metabolizing Enzyme (DME)
Drug Structure Similarity Search
Molecule Sequence Similarity Search
Download
Help
About
Details of the Drug Formulaction
General Information of Drug Formulation (ID: F22130)
Formulation Name
Vandetanib 100 mg tablet
Company
AstraZeneca
Pharmaceutical Drug(s) in Formulation
Drug Name
Drug ID
Indication
ICD 11
Status
Vandetanib
DMRICNP
Solid tumour/cancer
2A00-2F9Z
Approved
--------------------
Pharmaceutical Excipient(s) in Formulation
Excipient Name
Excipient ID
PubChem CID
Functional Classification
Brushite
E00392
104805
Diluent
Crospovidone
E00626
Not Available
Disintegrant
Magnesium stearate
E00208
11177
lubricant
Polyethylene glycol 300
E00651
Not Available
Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant
Povidone
E00667
Not Available
Binding agent; Coating agent; Disintegrant; Film/membrane-forming agent; Solubilizing agent; Suspending agent
Titanium dioxide
E00322
26042
Coating agent; Colorant; Opacifying agent
Water
E00035
962
Solvent
--------------------